Phase II trial of preoperative chemotherapy with docetaxel, cisplatin and S-1 for T4 locally advanced gastric cancer

Japanese Journal of Clinical Oncology

Volumn 42, Issue 2, 2012, Pages 131-133

  Fushida, Sachio ^a   Nashimoto, Atsushi ^b   Fukushima, Norimasa ^c   Kawachi, Yasuyuki ^d   Fujimura, Takashi ^a   Kuwabara, Shiro ^e   Musha, Nobuyuki ^f  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b NIIGATA CANCER CENTER HOSPITAL   (Japan)

^c Yamagata Prefectural Central Hospital   (Japan)

^d Nagaoka Chuo General Hospital   (Japan)

^e NIIGATA CITY GENERAL HOSPITAL   (Japan)

^f Saiseikai Niigata Daini Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;

ADULT; ADVANCED CANCER; ADVERSE OUTCOME; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DIARRHEA; DISEASE FREE SURVIVAL; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PREOPERATIVE TREATMENT; STOMACH CANCER; TREATMENT DURATION; TREATMENT RESPONSE;

ADENOCARCINOMA; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEASIBILITY STUDIES; FEMALE; GASTRECTOMY; HUMANS; INFUSIONS, INTRAVENOUS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; OXONIC ACID; PATIENT SELECTION; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TAXOIDS; TEGAFUR; TREATMENT OUTCOME;

EID: 84856620810     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyr183     Document Type: Article

References (9)

1. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007;357:1810-20.
2. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 2008;9:215-21.
3. Kodera Y, Ishiyama A, Yoshikawa T, Kinosita T, Ito S, Yokoyama H, et al. A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703). Gastric Cancer 2010;13:197-203.
4. Takahari D, Hamaguchi T, Yoshimura K, Katai H, Ito S, Fuse N, et al. Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer. Cancer Chemother Pharmacol 2011;1423-8.
5. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20.
6. Fujitani K, Sasako M, Iwasaki Y, Yoshimura K, Sano T, Nashimoto A, et al. A phase II study of preoperative chemotherapy (CX) with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancer: JCOG0210. In: Proceedings of the 43th ASCO Meeting (Abstr 4609), Chicago, 1-5 June, 2007.
7. Kurokawa Y, Sasako M, Ando N, Sano T, Igaki H, Iwasaki Y, et al. Validity of response criteria in neoadjuvant chemotherapy against gastric and esophageal cancer: correlative analyses of multicenter JCOG trials. In: Proceedings of the 45th ASCO Meeting (Abstr 11), Orland, 29 May- 2 June, 2009.
8. Fushida S, Fujimura T, Oyama K, Yagi Y, Kinoshita J, Ohta T. Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases. Anticancer Drugs 2009;20:752-6.
9. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma, 3rd English edition. Gastric Cancer 2011;14:101-12.